Literature DB >> 24145819

Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.

Andrew S P Lim1, Lei Yu, Matthew Kowgier, Julie A Schneider, Aron S Buchman, David A Bennett.   

Abstract

IMPORTANCE: The apolipoprotein E (APOE [GenBank, 348; OMIM, 107741]) ε4 allele is a common and well-established genetic risk factor for Alzheimer disease (AD). Sleep consolidation is also associated with AD risk, and previous work suggests that APOE genotype and sleep may interact to influence cognitive function.
OBJECTIVE: To determine whether better sleep consolidation attenuates the relationship of the APOE genotype to the risk of incident AD and the burden of AD pathology. DESIGN, SETTING, AND PARTICIPANTS: A prospective longitudinal cohort study with up to 6 years of follow-up was conducted. Participants included 698 community-dwelling older adults without dementia (mean age, 81.7 years; 77% women) in the Rush Memory and Aging Project. EXPOSURES: We used up to 10 days of actigraphic recording to quantify the degree of sleep consolidation and ascertained APOE genotype. MAIN OUTCOMES AND MEASURES: Participants underwent annual evaluation for AD during a follow-up period of up to 6 years. Autopsies were performed on 201 participants who died, and β-amyloid (Aβ) and neurofibrillary tangles were identified by immunohistochemistry and quantified.
RESULTS: During the follow-up period, 98 individuals developed AD. In a series of Cox proportional hazards regression models, better sleep consolidation attenuated the effect of the ε4 allele on the risk of incident AD (hazard ratio, 0.67; 95% CI, 0.46-0.97; P = .04 per allele per 1-SD increase in sleep consolidation). In a series of linear mixed-effect models, better sleep consolidation also attenuated the effect of the ε4 allele on the annual rate of cognitive decline. In individuals who died, better sleep consolidation attenuated the effect of the ε4 allele on neurofibrillary tangle density (interaction estimate, -0.42; SE = 0.17; P = .02), which accounted for the effect of sleep consolidation on the association between APOE genotype and cognition proximate to death. CONCLUSIONS AND RELEVANCE: Better sleep consolidation attenuates the effect of APOE genotype on incident AD and development of neurofibrillary tangle pathology. Assessment of sleep consolidation may identify APOE+ individuals at high risk for incident AD, and interventions to enhance sleep consolidation should be studied as potentially useful means to reduce the risk of AD and development of neurofibrillary tangles in APOE ε4+ individuals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24145819      PMCID: PMC3859706          DOI: 10.1001/jamaneurol.2013.4215

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  51 in total

1.  Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons.

Authors:  Aron S Buchman; Patricia A Boyle; Robert S Wilson; Todd L Beck; Jeremiah F Kelly; David A Bennett
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

2.  Association of sleep characteristics and cognition in older community-dwelling men: the MrOS sleep study.

Authors:  Terri Blackwell; Kristine Yaffe; Sonia Ancoli-Israel; Susan Redline; Kristine E Ensrud; Marcia L Stefanick; Alison Laffan; Katie L Stone
Journal:  Sleep       Date:  2011-10-01       Impact factor: 5.849

3.  Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Authors:  J Lewis; D W Dickson; W L Lin; L Chisholm; A Corral; G Jones; S H Yen; N Sahara; L Skipper; D Yager; C Eckman; J Hardy; M Hutton; E McGowan
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

4.  Increased fragmentation of rest-activity patterns is associated with a characteristic pattern of cognitive impairment in older individuals.

Authors:  Andrew S P Lim; Lei Yu; Madalena D Costa; Sue E Leurgans; Aron S Buchman; David A Bennett; Clifford B Saper
Journal:  Sleep       Date:  2012-05-01       Impact factor: 5.849

5.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology.

Authors:  J A Schneider; R S Wilson; J L Bienias; D A Evans; D A Bennett
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

6.  Sleep-disordered breathing in community-dwelling elderly.

Authors:  S Ancoli-Israel; D F Kripke; M R Klauber; W J Mason; R Fell; O Kaplan
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

7.  Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles.

Authors:  David A Bennett; Philip L De Jager; Sue E Leurgans; Julie A Schneider
Journal:  Neurology       Date:  2009-04-28       Impact factor: 9.910

8.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Association of sleep disordered breathing and cognitive deficit in APOE ε4 carriers.

Authors:  Maria Nikodemova; Laurel Finn; Emmanuel Mignot; Nicole Salzieder; Paul E Peppard
Journal:  Sleep       Date:  2013-06-01       Impact factor: 5.849

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  100 in total

1.  Examining the association between Apolipoprotein E (APOE) and self-reported sleep disturbances in non-demented older adults.

Authors:  Angeliki Tsapanou; Nikolaos Scarmeas; Yian Gu; Jennifer Manly; Nicole Schupf; Yaakov Stern; Sandra Barral
Journal:  Neurosci Lett       Date:  2015-08-24       Impact factor: 3.046

2.  Alzheimer disease: Sleep alleviates AD-related neuropathological processes.

Authors:  Hemi Malkki
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

3.  Sleep fragmentation and Parkinson's disease pathology in older adults without Parkinson's disease.

Authors:  Shahmir Sohail; Lei Yu; Julie A Schneider; David A Bennett; Aron S Buchman; Andrew S P Lim
Journal:  Mov Disord       Date:  2017-10-30       Impact factor: 10.338

4.  Sleep Disturbance and the Risk of Cognitive Decline or Clinical Conversion in the ADNI Cohort.

Authors:  Adam P Mecca; Hannah R Michalak; Julia W McDonald; Emily C Kemp; Erika A Pugh; Melinda L Becker; Marcia C Mecca; Christopher H van Dyck
Journal:  Dement Geriatr Cogn Disord       Date:  2018-06-08       Impact factor: 2.959

Review 5.  Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease.

Authors:  Md Sahab Uddin; Dewan Md Sumsuzzman; Philippe Jeandet; Tapan Behl; Abdur Rauf; Md Shah Amran; Ghulam Md Ashraf
Journal:  Neurochem Res       Date:  2021-04-19       Impact factor: 3.996

6.  Waking Up MRI-Visible Perivascular Spaces and Drainage Research.

Authors:  Andreas Charidimou; Sergi Martinez-Ramirez; Anand Viswanathan
Journal:  Sleep       Date:  2015-06-01       Impact factor: 5.849

Review 7.  Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research.

Authors:  Michael K Scullin; Donald L Bliwise
Journal:  Perspect Psychol Sci       Date:  2015-01

Review 8.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

9.  Abnormal Sleep Behaviours Across the Spectrum of Alzheimer's Disease Severity: Influence of APOE Genotypes and Lewy Bodies.

Authors:  Ka Yi G Koo; Tom A Schweizer; Corinne E Fischer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2019       Impact factor: 3.498

10.  Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.

Authors:  Ricardo S Osorio; Emma L Ducca; Margaret E Wohlleber; Emily B Tanzi; Tyler Gumb; Akosua Twumasi; Samuel Tweardy; Clifton Lewis; Esther Fischer; Viachaslau Koushyk; Maria Cuartero-Toledo; Mohammed O Sheikh; Elizabeth Pirraglia; Henrik Zetterberg; Kaj Blennow; Shou-En Lu; Lisa Mosconi; Lidia Glodzik; Sonja Schuetz; Andrew W Varga; Indu Ayappa; David M Rapoport; Mony J de Leon
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.